Vascular-targeted overexpression of G protein-coupled receptor kinase-2 in transgenic mice attenuates beta-adrenergic receptor signaling and increases resting blood pressure - PubMed (original) (raw)
Vascular-targeted overexpression of G protein-coupled receptor kinase-2 in transgenic mice attenuates beta-adrenergic receptor signaling and increases resting blood pressure
Andrea D Eckhart et al. Mol Pharmacol. 2002 Apr.
Abstract
Cardiovascular regulation is tightly controlled by signaling through G protein-coupled receptors (GPCRs). beta-Adrenergic receptors (ARs) are GPCRs that regulate inotropy and chronotropy in the heart and mediate vasodilation, which critically influences systemic vascular resistance. GPCR kinases (GRKs), including GRK2 (or betaARK1), phosphorylate and desensitize agonist-activated betaARs. Myocardial GRK2 levels are increased in heart failure and data suggest that vascular levels may also be elevated in hypertension. Therefore, we generated transgenic mice with vascular smooth muscle (VSM) targeted overexpression of GRK2, using a portion of the SM22alpha promoter, to determine its impact on vascular betaAR regulation. VSM betaAR signaling, as determined by adenylyl cyclase and mitogen-activated protein (MAP) kinase activation assays, was attenuated when GRK2 was overexpressed 2- to 3-fold. In vivo vasodilation in response to betaAR stimulation using isoproterenol was attenuated and conscious resting mean arterial blood pressure was elevated from 96 +/- 2 mm Hg in nontransgenic littermate control (NLC) mice (n = 9) to 112 +/- 3 mm Hg and 117 +/- 2 mm Hg in two different lines of SM22alpha-GRK2 transgenic mice (n = 7 and n = 5, respectively; p < 0.05). Interestingly, medial VSM thickness was increased 30% from 29.8 +/- 1.6 microm in NLC mice (n = 6) to 39.4 +/- 1.6 microm in SM22alpha-GRK2 mice (n = 7) (p < 0.05) and vascular GRK2 overexpression was sufficient to cause cardiac hypertrophy. These data indicate that we have developed a unique mouse model of hypertension, providing insight into the contribution that vascular betaAR signaling makes toward resting blood pressure and overall cardiovascular regulation. Moreover, they suggest that GRK2 plays an important role in vascular control and may represent a novel therapeutic target for hypertension.
Similar articles
- In vivo inhibition of elevated myocardial beta-adrenergic receptor kinase activity in hybrid transgenic mice restores normal beta-adrenergic signaling and function.
Akhter SA, Eckhart AD, Rockman HA, Shotwell K, Lefkowitz RJ, Koch WJ. Akhter SA, et al. Circulation. 1999 Aug 10;100(6):648-53. doi: 10.1161/01.cir.100.6.648. Circulation. 1999. PMID: 10441103 - Hybrid transgenic mice reveal in vivo specificity of G protein-coupled receptor kinases in the heart.
Eckhart AD, Duncan SJ, Penn RB, Benovic JL, Lefkowitz RJ, Koch WJ. Eckhart AD, et al. Circ Res. 2000 Jan 7-21;86(1):43-50. doi: 10.1161/01.res.86.1.43. Circ Res. 2000. PMID: 10625304 - The beta-adrenergic receptor kinase in heart failure.
Petrofski JA, Koch WJ. Petrofski JA, et al. J Mol Cell Cardiol. 2003 Oct;35(10):1167-74. doi: 10.1016/s0022-2828(03)00243-8. J Mol Cell Cardiol. 2003. PMID: 14519424 Review. - Phosphorylation of G protein-coupled receptors: GPCR kinases in heart disease.
Hata JA, Koch WJ. Hata JA, et al. Mol Interv. 2003 Aug;3(5):264-72. doi: 10.1124/mi.3.5.264. Mol Interv. 2003. PMID: 14993440 Review.
Cited by
- The role of G protein coupled receptor kinases in neurocardiovascular pathophysiology.
Bojic T, Sudar E, Mikhailidis D, Alavantic D, Isenovic E. Bojic T, et al. Arch Med Sci. 2012 Dec 20;8(6):970-7. doi: 10.5114/aoms.2012.29996. Epub 2012 Dec 19. Arch Med Sci. 2012. PMID: 23319968 Free PMC article. - Angiotensin Receptors Heterodimerization and Trafficking: How Much Do They Influence Their Biological Function?
Rukavina Mikusic NL, Silva MG, Pineda AM, Gironacci MM. Rukavina Mikusic NL, et al. Front Pharmacol. 2020 Aug 3;11:1179. doi: 10.3389/fphar.2020.01179. eCollection 2020. Front Pharmacol. 2020. PMID: 32848782 Free PMC article. Review. - Targeting G protein-coupled receptor signalling by blocking G proteins.
Campbell AP, Smrcka AV. Campbell AP, et al. Nat Rev Drug Discov. 2018 Nov;17(11):789-803. doi: 10.1038/nrd.2018.135. Epub 2018 Sep 28. Nat Rev Drug Discov. 2018. PMID: 30262890 Free PMC article. Review. - GRK5 - A Functional Bridge Between Cardiovascular and Neurodegenerative Disorders.
Hendrickx JO, van Gastel J, Leysen H, Santos-Otte P, Premont RT, Martin B, Maudsley S. Hendrickx JO, et al. Front Pharmacol. 2018 Dec 17;9:1484. doi: 10.3389/fphar.2018.01484. eCollection 2018. Front Pharmacol. 2018. PMID: 30618771 Free PMC article. Review. - G Protein-Coupled Receptor Kinase 2 (GRK2) as a Potential Therapeutic Target in Cardiovascular and Metabolic Diseases.
Murga C, Arcones AC, Cruces-Sande M, Briones AM, Salaices M, Mayor F Jr. Murga C, et al. Front Pharmacol. 2019 Feb 19;10:112. doi: 10.3389/fphar.2019.00112. eCollection 2019. Front Pharmacol. 2019. PMID: 30837878 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Molecular Biology Databases